321 related articles for article (PubMed ID: 23936991)
1. Cognitive enhancement effects of Bacopa monnieri (Brahmi) on novel object recognition and NMDA receptor immunodensity in the prefrontal cortex and hippocampus of sub-chronic phencyclidine rat model of schizophrenia.
Piyabhan P; Wetchateng T; Sireeratawong S
J Med Assoc Thai; 2013 Feb; 96(2):231-8. PubMed ID: 23936991
[TBL] [Abstract][Full Text] [Related]
2. Cognitive enhancement effects of Bacopa monnieri (Brahmi) on novel object recognition and VGLUT1 density in the prefrontal cortex, striatum, and hippocampus of sub-chronic phencyclidine rat model of schizophrenia.
Piyabhan P; Wetchateng T
J Med Assoc Thai; 2013 May; 96(5):625-32. PubMed ID: 23745319
[TBL] [Abstract][Full Text] [Related]
3. Bacopa monnieri (Brahmi) Enhanced Cognitive Function and Prevented Cognitive Impairment by Increasing VGLUT2 Immunodensity in Prefrontal Cortex of Sub-Chronic Phencyclidine Rat Model of Schizophrenia.
Piyabhan P; Wetchateng T
J Med Assoc Thai; 2015 Apr; 98 Suppl 3():S7-15. PubMed ID: 26387382
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effects of Bacopa monnieri (Brahmi) on novel object recognition and NMDAR1 immunodensity in the prefrontal cortex, striatum and hippocampus of sub-chronic phencyclidine rat model of schizophrenia.
Piyabhan P; Wetchateng T
J Med Assoc Thai; 2014 Aug; 97 Suppl 8():S50-5. PubMed ID: 25518293
[TBL] [Abstract][Full Text] [Related]
5. Bacopa monnieri (Brahmi) Prevents Cognitive Deficit by Maintaining CA2/3 VGLUT1 Density of Sub-Chronic Phencyclidine Rat Model of Schizophrenia in Normal Level.
Piyabhan P; Wetchateng T
J Med Assoc Thai; 2016 Jul; 99 Suppl 4():S222-9. PubMed ID: 29926716
[TBL] [Abstract][Full Text] [Related]
6. Bacopa monnieri (Brahmi) improved novel object recognition task and increased cerebral vesicular glutamate transporter type 3 in sub-chronic phencyclidine rat model of schizophrenia.
Piyabhan P; Wannasiri S; Naowaboot J
Clin Exp Pharmacol Physiol; 2016 Dec; 43(12):1234-1242. PubMed ID: 27562725
[TBL] [Abstract][Full Text] [Related]
7. Cognitive enhancement effects of Bacopa monnieri (Brahmi) on novel object recognition and neuronal density in the prefrontal cortex, striatum and hippocampus in sub-chronic phencyclidine administration rat model of schizophrenia.
Wetchateng T; Piyabhan P
J Med Assoc Thai; 2015 Mar; 98 Suppl 2():S56-63. PubMed ID: 26211105
[TBL] [Abstract][Full Text] [Related]
8. Effect of pre- and post-treatment with
Piyabhan P; Tingpej P; Duansak N
Neuropsychiatr Dis Treat; 2019; 15():1103-1117. PubMed ID: 31118643
[No Abstract] [Full Text] [Related]
9. Animal model of schizophrenia: dysfunction of NMDA receptor-signaling in mice following withdrawal from repeated administration of phencyclidine.
Nabeshima T; Mouri A; Murai R; Noda Y
Ann N Y Acad Sci; 2006 Nov; 1086():160-8. PubMed ID: 17185514
[TBL] [Abstract][Full Text] [Related]
10. Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat.
Abdul-Monim Z; Neill JC; Reynolds GP
J Psychopharmacol; 2007 Mar; 21(2):198-205. PubMed ID: 17329300
[TBL] [Abstract][Full Text] [Related]
11. The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm.
Abdul-Monim Z; Reynolds GP; Neill JC
Behav Brain Res; 2006 May; 169(2):263-73. PubMed ID: 16500717
[TBL] [Abstract][Full Text] [Related]
12. Involvement of a dysfunctional dopamine-D1/N-methyl-d-aspartate-NR1 and Ca2+/calmodulin-dependent protein kinase II pathway in the impairment of latent learning in a model of schizophrenia induced by phencyclidine.
Mouri A; Noda Y; Noda A; Nakamura T; Tokura T; Yura Y; Nitta A; Furukawa H; Nabeshima T
Mol Pharmacol; 2007 Jun; 71(6):1598-609. PubMed ID: 17344353
[TBL] [Abstract][Full Text] [Related]
13. Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat.
Grayson B; Idris NF; Neill JC
Behav Brain Res; 2007 Nov; 184(1):31-8. PubMed ID: 17675172
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the phencyclidine-induced increase in prefrontal cortical dopamine metabolism in the rat.
Umino A; Takahashi K; Nishikawa T
Br J Pharmacol; 1998 May; 124(2):377-85. PubMed ID: 9641556
[TBL] [Abstract][Full Text] [Related]
15. The role of the hippocampo-prefrontal cortex system in phencyclidine-induced psychosis: a model for schizophrenia.
Jodo E
J Physiol Paris; 2013 Dec; 107(6):434-40. PubMed ID: 23792022
[TBL] [Abstract][Full Text] [Related]
16. Oestradiol attenuates the cognitive deficit induced by acute phencyclidine treatment in mature female hooded-Lister rats.
Sutcliffe JS; Rhaman F; Marshall KM; Neill JC
J Psychopharmacol; 2008 Nov; 22(8):918-22. PubMed ID: 18208936
[TBL] [Abstract][Full Text] [Related]
17. Rapid cortico-limbic alterations in AMPA receptor densities after administration of PCP: implications for schizophrenia.
Zavitsanou K; Nguyen V; Newell K; Ballantyne P; Huang XF
J Chem Neuroanat; 2008 Oct; 36(2):71-6. PubMed ID: 18640263
[TBL] [Abstract][Full Text] [Related]
18. Prefrontal NMDA receptor antagonism reduces impairments in pre-attentive information processing.
Klamer D; Svensson L; Fejgin K; PĂ„lsson E
Eur Neuropsychopharmacol; 2011 Mar; 21(3):248-53. PubMed ID: 21111580
[TBL] [Abstract][Full Text] [Related]
19. [Neuropsychopharmacological study on an animal model for negative symptom of schizophrenia induced by repeated phencyclidine treatment].
Noda Y; Nabeshima T
Yakugaku Zasshi; 2000 Aug; 120(8):677-82. PubMed ID: 10946617
[TBL] [Abstract][Full Text] [Related]
20. Chronic infusion of PCP via osmotic mini-pumps: a new rodent model of cognitive deficit in schizophrenia characterized by impaired attentional set-shifting (ID/ED) performance.
Pedersen CS; Goetghebeur P; Dias R
J Neurosci Methods; 2009 Dec; 185(1):66-9. PubMed ID: 19761795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]